The Leucegene project will help pave the way for a new era in personalized medicine and offer patients better targeted therapies


The Leucegene team utilises Next-Generation sequencing, chemogenomic and precision medicine approaches to develop innovative tools, treatments and collaborations to cure AML.

Health Care Providers

We have developed a new prognostic test and look to drive implementation through socio-economic studies and clinician engagement.


Our Leucegene approach will refine precision medicine in AML and provide cures for this disease.


New publication in Clinical Cancer Research

Chemogenomic landscape of RUNX1-mutated AML reveals importance…

Recent publication of the Leucegene team in Blood Cancer Journal

Bacelli et al. published A novel approach for the identification…

Our Partners